What Happened?
Palo Alto, -based Jazz-Pharmaceuticals Resigned Suzanne Hooper as Executive Vice President and General Counsel
About the Company
Our mission is to improve patients’ lives by identifying, developing and commercializing important specialty pharmaceutical products to address unmet patient needs. We address serious diseases, always with the goal of improving patient care. Keeping patients at the forefront of our mind inspires us to bring innovative and valuable resources to all aspects of our business for the ultimate benefit of the patients in need.
About the Person
Suzanne Sawochka Hooper has been Executive Vice President and General Counsel of Jazz Pharmaceuticals plc since January 24, 2012. Ms. Hooper has been the Executive Vice President and General Counsel of Jazz Pharmaceuticals Public Limited Company since March 2012. She serves at Cooley Godward Kronish LLP. From 1996 through early 2012, she was a Partner at the law firm Cooley LLP. Ms. Hooper has been a Director of Gentium S.p.A. since January 23, 2014. Ms. Hooper served for several years as a member of Cooley’s Management Committee and Vice Chair of the Business department. While at Cooley, Ms. Hooper practiced corporate and securities law, primarily with companies and investors in the life sciences industry, and with an emphasis on securities transactions and mergers and acquisitions. Ms. Hooper received a J.D. from the University of California, Berkeley, Boalt Hall School of Law and a B.A. in Political Science from the University of California, Santa Barbara. Ms. Hooper is a member of the State Bar of California.
Info Source
News
Short Profile